mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-06 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |